The General Meeting is Remedy’s highest decision-making body. The shareholders take part in the supervision and governance of Remedy through the resolutions of the General Meetings. The General Meeting is generally convened by the Board of Directors. Furthermore, according to the Limited Liability Companies Act, a General Meeting of shall be held if the company’s auditor or shareholders representing a minimum of one-tenth of all outstanding shares in the company demand in writing that a General Meeting be convened.
According to the Articles of Association, the Annual General Meeting shall be held annually within six months of the termination of the financial year on a date determined by the Board of Directors.
The General Meeting shall present the financial statements comprising the income statement, balance sheet and auditing report.
The Annual General Meeting decides on the matters determined by the Limited Liability Companies Act, including the adoption of the financial statements, distribution of profit and the discharge from liability for the members of the Board of Directors and the Chief Executive Officer. The General Meeting also elects the members of the Board of Directors and auditors, and decides on their remuneration, respectively.
Notice to General Meeting
According to the Articles of Association, the notice convening a General Meeting shall be published on the company’s website no earlier than three (3) months and no later than three (3) weeks prior to the Meeting, but no later than nine (9) days before the record date of the meeting. According to the Articles of Association, in order to be entitled to attend the General Meeting, a shareholder must notify the company of its attendance by the date specified in the notice convening the Meeting, which date may not be earlier than ten (10) days prior to the Meeting.
Attending the General Meeting
Shareholders, who have no later than eight business days prior to the General Meeting (record date of the General Meeting) entered into the list of shareholders maintained by Euroclear Finland, and who have notified the company of their attendance no later than on the date indicated on the notice to the General Meeting, or nominee registered shareholders, who have been temporarily entered into the list of shareholders in order to attend the Meeting, shall have the right to attend the General Meeting.
Shareholders may attend the General Meeting and exercise their voting right either in person or via an authorized proxy. Each Remedy share is entitled to one vote. If a nominee registered shareholder wishes to attend the General Meeting and exercise their voting right, they shall register the shares temporarily under their own name in the list of shareholders maintained by Euroclear Finland. Temporary entry into the list shall be made no later than on the date indicated on the notice to the General Meeting, which shall postdate the record date of the General Meeting. Nominee registered shareholders are considered attendees to the General Meeting upon their temporary entry to the list of shareholders. Neither the Limited Liability Companies Act nor the Articles of Association have set a specific number of attendees as the quorum requirement of the General Meeting.